Patents Assigned to HESPERIX SA
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20220018845
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: July 26, 2021
    Publication date: January 20, 2022
    Applicants: HESPERIX SA, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Alexander Gabibovich Gabibov, Richard A. Lerner, Alexey Anatolievich Belogurov, Jia Xie
  • Articles and methods directed to personalized therapy of cancer
    Patent number: 11215618
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Grant
    Filed: August 3, 2020
    Date of Patent: January 4, 2022
    Assignees: HESPERIX SA, The Scripps Research Institute
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie
  • ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER
    Publication number: 20210333282
    Abstract: Described are methods for providing personalized medicine for the treatment of B cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.
    Type: Application
    Filed: August 3, 2020
    Publication date: October 28, 2021
    Applicants: HESPERIX SA, The Scripps Research Institute
    Inventors: Alexey Vyacheslavovich Stepanov, Dmitry Dmitrievich Genkin, Richard A. Lerner, Alexey Anatolievich Belogurov, Alexander Gabibovich Gabibov, Jia Xie